Results 281 to 290 of about 1,778,305 (310)

The anti-cancer agent APR-246 can activate several programmed cell death processes to kill malignant cells

Cell Death and Differentiation, 2023
Kelly L Rogers, Connie S N Li-Wai-Suen, Elizabeth Lieschke   +2 more
exaly  

APR

2006
openaire   +2 more sources

Preliminary neutronic analysis of alternative cladding materials for APR-1400 fuel assembly

Nuclear Engineering and Design, 2021
Mohammad Alrwashdeh, Saeed A Alameri
exaly  

APhA-APRS

Journal of the American Pharmacists Association, 2007
openaire   +1 more source

APR-246/PRIMA-1MET inhibits thioredoxin reductase 1 and converts the enzyme to a dedicated NADPH oxidase

Cell Death and Disease, 2013
Klas G Wiman, Elias Arnér
exaly  

APR-246 (PRIMA-1 MET ) strongly synergizes with AZD2281 (olaparib) induced PARP inhibition to induce apoptosis in non-small cell lung cancer cell lines

Cancer Letters, 2016
Christophe Deben, Filip Lardon, An Wouters   +2 more
exaly  

“Apres‐Congress”

AORN Journal, 1971
openaire   +1 more source

APR-246 potently inhibits tumour growth and overcomes chemoresistance in preclinical models of oesophageal adenocarcinoma

Gut, 2015
Assoc Prof Carleen Cullinane, Sue Haupt, Ygal Haupt   +2 more
exaly  

APR

2005
openaire   +1 more source

PRIMA-1MET/APR-246 targets mutant forms of p53 family members p63 and p73

Oncogene, 2010
Klas G Wiman
exaly